HIPEX
Develops large-scale Hot Isostatic Pressing (HIP) systems and provides densification services to eliminate internal defects in metal AM parts for aerospace and medical use.
- CEO / Founder
- Wu Zhanfang
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Corporate Round - Undisclosed - January 2005
- Key Investors
- CISRI Group
Technology & Products
Key Products
RD Series HIP Equipment; HIP Densification Services; Diffusion Bonding Services; Near-Net Shape (NNS) Powder Metallurgy
Technological Advantage
Proprietary rapid cooling technology reduces HIP cycle times by up to 40%, while deep integration with CISRI materials research provides superior process optimization for exotic alloys.
Differentiation
Value Proposition
Eliminates internal porosity in metal AM parts to achieve 100% theoretical density, significantly improving fatigue life and mechanical reliability for mission-critical applications.
How They Differentiate
Integrates 60 years of state-backed materials science expertise with the largest HIP service capacity in China, offering lower costs and faster turnaround for domestic aerospace programs compared to international providers.
Market & Competition
Target Customers
Aerospace OEMs, medical implant manufacturers, and metal AM service bureaus requiring high-integrity components.
Industry Verticals
Aerospace; Medical; Energy; Defense; Automotive
Competitors
Quintus Technologies; Bodycote; Kobe Steel; EPSI
Growth & Milestones
Growth Metrics
Operates 4 regional HIP service centers (Beijing, Zhenjiang, Qingdao, Weinan) with 17 HIP units ranging from lab-scale to D1850mm large-format systems.
Major Milestones
Achieved NADCAP and AS9100 aerospace certifications; Developed China's largest HIP equipment (D1850*3500mm); Established 4 regional service centers to support the growing AM supply chain
Notable Customers
AVIC; COMAC; AECC; Various Chinese Medical Implant Manufacturers